Navigation Links
DURATION-6 Top-Line Study Results Announced
Date:3/3/2011

mes. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYDUREON may not be approved by the FDA and/or the European Commission as soon as anticipated or at all; the companies' response to the FDA's complete response letter may not be submitted in a timely manner and/or the information provided in such response may not satisfy the FDA; the FDA may request additional information prior to approval; BYETTA and/or the approval of BYDUREON and future revenues from BYDUREON, if approved, and/or BYETTA (exenatide for injection) may be affected by competition; unexpected new data; safety and technical issues; clinical trials, including the clinical trial mentioned in this press release, not being completed in a timely manner, not confirming previous results, not being predictive of real world use or not achieving the intended clinical endpoints; label expansion requests or NDA filings not receiving regulatory approval; the commercial launch of BYDUREON being delayed; or manufacturing and supply issues. The potential for BYETTA and/or BYDUREON may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical products including those inherent in the collaboration with and dependence upon Amylin, Lilly and/or Alkermes. These and additional risks and uncertainties are described more fully in Amylin's, Lilly's and Alkermes' most recent SEC filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin, Lilly and Alkermes undertake no duty to update these forward-looking statements.

BYDUREON™ and BYETTA® are trademarks of Amylin Pharmaceuticals, Inc., and Medisorb® is a registered trademark of Alkerme
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen Announces Top-Line Phase II Results on Velafermin
2. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Schering-Plough Reports Top-Line Results of the IDEAL Study
5. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
6. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
7. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
8. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
9. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
10. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
11. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... N.C. , May 1, 2015  An ... that can provide non-binding but informed guidance to ... the return on investment, it is important for ... invest optimal resources. Research and ... study to assist pharmaceutical and medical device executives ...
(Date:5/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vzcw2v/americas_clinical ) has announced ... by Product, by End-Users - Forecast to 2019" report ... market is estimated to grow at a CAGR of 5.2% ... Canada , Mexico , ... covered in this report. The Americas is the ...
(Date:5/1/2015)... 2015 Following yesterday,s release of Center for Medicaid ... five things you need to know: ... unique among government programs. ... than other parts of Medicare and other government programs because ... to offer prescription drug benefits to enrollees. , Competition ...
Breaking Medicine Technology:New Study Presents Insights to Advisory Board Effectiveness in the Pharmaceutical Sector 2Americas Clinical Chemistry Analyzer (Semi-Automated Clinical Chemistry and Fully-Automated Clinical Chemistry) Market - Forecast to 2019 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3
... 1, 2012 The FDA and representatives from the ... on proposed recommendations for the third reauthorization of a ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The recommendations would authorize the ... five years, plus adjustments for inflation. Details of the ...
... Corporation (NYSE: BSX ) announces first ... PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent ... the new device was performed by Professor Antonio ... at Columbus Hospital and San Raffaele Hospital in ...
Cached Medicine Technology:FDA and Industry Reach Agreement in Principle on Medical Device User Fees 2FDA and Industry Reach Agreement in Principle on Medical Device User Fees 3Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 2Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 3Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe 4
(Date:5/3/2015)... “ BolehVPN ” was featured on NewsWatch as ... and coolest technology products available to consumers. Scott Steinberg, a ... and shared with viewers how to protect their private information. ... on computers and even more so online. It helps everyone ... over the world. In terms of work, the internet makes ...
(Date:5/3/2015)... May 03, 2015 SpineFrontier, a Less ... the FDA to produce and market their new sacroiliac ... be used in outpatient settings and is compatible with ... posterior approach has been extensively researched and refined by ... to use this approach in conjunction with a sacroiliac ...
(Date:5/2/2015)... As one of only 30 Illinois companies to be ... and Recognition Program (SHARP) certification, Essentra Specialty Tapes ... Department of Labor to host this special event. ... the Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation ... or exceed all of the necessary regulations and standards, ...
(Date:5/2/2015)... “ ActOn ” was featured on NewsWatch ... at the latest and coolest applications on the market for ... and technology expert, conducted the app review and shared with ... organizations to make a difference. , In this material world, ... that aren’t about money, which is why those things should ...
(Date:5/2/2015)... We are pleased to announce the Sun ... one of the Top Workplaces of 2015. , The ... field for their ethics and standards of excellence. The ... their educational efforts. The Delray Recovery Center prides itself ... purpose – to help individuals heal from the disease ...
Breaking Medicine News(10 mins):Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2Health News:The Delray Recovery Center Named 2015 Top Workplace 2
... factors for spontaneous or unexpected preterm birth any birth ... without a known cause is already having had one. ... this scenario in their second pregnancy, focusing on weight gain ... new study reported at the Society for Maternal-Fetal Medicine,s annual ...
... HealthDay Reporter , THURSDAY, Feb. 9 (HealthDay News) -- A ... had chemotherapy while pregnant aren,t at higher risk for a ... be safe for the fetus in most instances. There,s ... were more likely to be born prematurely, potentially putting them ...
... Annual Meeting of the American Academy of Orthopaedic Surgeons ... living with a total knee replacement (TKR), as the ... the past decade, with the sharpest rise among younger ... TKR., Investigators used a computer model; U.S. Census data; ...
... (February 10, 2012) In a study to be ... meeting, The Pregnancy Meeting , in Dallas, Texas, researchers ... can be used to diagnose fetal aneuploidies, including Down ... Because of the importance of the clinical data, the ...
... obstructive sleep apnea had substantial improvements in attention, anxiety ... pressure (PAP)a nighttime therapy in which a machine delivers ... nose. "The benefits occurred even when children ... Carole L. Marcus, M.D., a sleep specialist and director ...
... , THURSDAY, Feb. 9 (HealthDay News) -- Small, premature ... higher risk for serious breathing problems than those delivered ... syndrome, which mostly affects premature newborns and can lead ... more common in the babies born by cesarean, or ...
Cached Medicine News:Health News:To avoid early labor and delivery, weight and diet changes not the answer 2Health News:Chemo During Pregnancy Doesn't Seem to Harm Baby 2Health News:Chemo During Pregnancy Doesn't Seem to Harm Baby 3Health News:4.5 million Americans living with total knee replacement 2Health News:Study finds massively parallel sequencing can detect fetal aneuploidies, including Down syndrome 2Health News:Sleep breathing machine shows clear benefits in children with sleep apnea 2Health News: C-Sections Might Put Preemies at Risk for Breathing Problems 2Health News: C-Sections Might Put Preemies at Risk for Breathing Problems 3
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... Many special order products are offered as ... long lengths. The modular instruments may be ... options such as ratchets, insulation and flush ... Mediflex stock. Customer specifications may affect delivery ...
... are offered as 1-piece or modular, in ... instruments may be customized with handles of ... insulation and flush ports. Many standard patterns ... may affect delivery times. , Please ...
... offered as 1-piece or modular, in regular ... may be customized with handles of choice ... and flush ports. Many standard patterns are ... affect delivery times. , Please Note: ...
Medicine Products: